HEREHilton Head Island
Why It Matters. HERE!
Latest Italian Maker ERRECINQUE Plans $5M Bluffton, S.C. Facility
☁ 36°F Clear · Hilton Head IslandFORECAST
HILTON HEAD ISLAND, SC · LOWCOUNTRY / BEAUFORT COUNTY EDITION · MONDAY, NOVEMBER 16, 2026
HERE City Network
Business

Sun Pharma Lines Up $4 Billion Loan to Refinance Organon Bridge

Published November 16, 2026 at 5:57 am | By Merger Monday, Staff Reporter

Sun Pharma Organon bridge loan refinancing: Sun Pharma Lines Up $4 Billion Loan to Refinance Organon Bridge

Sun Pharmaceutical Industries Ltd. is arranging a $4 billion syndicated loan to replace part of the short-term bridge financing that backs its $11.75 billion acquisition of U.S. drugmaker Organon & Co., people familiar with the transaction said.

Five banks, Citibank, MUFG, Standard Chartered, BNP Paribas and DBS Bank, are expected to commit about $800 million each as lead arrangers and are finalizing terms, the people said. The loan would run five years and pay a margin of roughly 110 to 120 basis points over the Secured Overnight Financing Rate, which sits near 3.9%. It is expected to launch into senior syndication this week, with three or four more lenders joining before the facility is signed.

HERE CITY BUSINESS DIRECTORYOwn a business in Hilton Head Island? Get listed HERE.Free basic listing. Premium features available.
ADD YOUR BUSINESS →

Taking out the bridge

Sun agreed in April to buy Organon, the Merck spinoff that sells health products for women, biosimilars and established brands, at an enterprise value of $11.75 billion. It funded the deal with an 18-month bridge loan from a group of 12 banks that included MUFG and State Bank of India. Replacing bridge money with longer-term debt is the usual next step once a buyer can see the path to closing, and it lowers the risk of having to refinance a large sum in a rush.

The company recently raised 7,816 crore rupees, or more than $800 million, by selling local non-convertible debentures priced at 8.05% for five years and 8.20% for seven years, and part of that money could also go toward repaying the bridge. Sun is also weighing more rupee debentures, equity and possibly dollar bonds as part of the broader financing plan, the people said. Sun Pharma and the banks declined to comment or did not respond.

What Sun is buying

Organon reported revenue of $6.2 billion in 2025 and adjusted operating profit of about $2 billion, a margin of roughly 31%, and revenue held steady above $3 billion in the first half of 2026, a ratings agency report said. Organon shareholders have approved the deal, which is expected to close in late 2026 or early 2027 as regulatory approvals arrive in different countries.

The loan would be among the largest syndicated financings for an Indian company this year and reflects how global banks are competing to fund outbound acquisitions by Indian groups as they buy assets in the U.S. and Europe.

SPONSOR | Your Business Here — Be the brand Hilton Head Island's Business community sees first every morning. Exclusive top-of-section placement, Monday–Friday.
SPONSOR $199/MO →

Section: More Hilton Head Island SC business news

Hilton Head Island business profiles

Filed under: Hilton Head Island SC Business News

Merger Monday
HERE Hilton Head · BUSINESS

Merger is a staff reporter for HERE Hilton Head covering local news, community stories, and developments across Beaufort County. Merger is committed to accurate, community-first journalism.

Contact Merger
HEREmention Get Your Business Found in AI BE THE ANSWER. When customers ask ChatGPT, Perplexity, or Google AI who to hire — your name comes up. Learn More

BUSINESS NEWS NEAR HILTON HEAD ISLAND SC

Business coverage from the 10 closest HERE cities.